The treatable traits approach to adults with obstructive airways disease in primary and secondary care

Biologic Therapies for Severe Asthma

(2022) Guy G. Brusselle et al.   NEW ENGLAND JOURNAL OF MEDICINE

The use of treatable traits to address COPD complexity and heterogeneity and to inform the care

(2022) Katarzyna Duszyk et al.   Breathe

Occupational COPD —The most under‐recognized occupational lung disease?

(2022) Nicola Murgia et al.   RESPIROLOGY

Effectiveness of interventions targeting treatable traits for the management of obstructive airway diseases: a systematic review and meta-analysis

(2022) Muhammad Rehan Sarwar et al.   Journal of Allergy and Clinical Immunology-In Practice

Treatable traits in the NOVELTY study

(2022) Alvar Agustí et al.   RESPIROLOGY

Assessment of real-world escalation to biologics in US patients with asthma

(2022) Bruce Bender et al.   Journal of Allergy and Clinical Immunology-In Practice

Does pulmonary rehabilitation address treatable traits? A systematic review

(2022) Anne E. Holland et al.   European Respiratory Review

Long-Term Telerehabilitation or Unsupervised Training at Home for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

(2022) Paolo Zanaboni et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Balancing the needs of the many and the few: where next for adult asthma guidelines?

(2021) Dominick E Shaw et al.   Lancet Respiratory Medicine

Prediction of Mortality Using Different COPD Risk Assessments – A 12-Year Follow-Up

(2021) Asa Athlin et al.   International Journal of Chronic Obstructive Pulmonary Disease

Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review

(2021) Janine Mahoney et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

(2021) Roland Buhl et al.   Journal of Allergy and Clinical Immunology-In Practice

Optimal Asthma Control: Time for a New Target

(2020) Richard Beasley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme

(2020) Bright I. Nwaru et al.   EUROPEAN RESPIRATORY JOURNAL

Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use

(2020) Eve Denton et al.   Journal of Allergy and Clinical Immunology-In Practice

Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries

(2020) Peter K. Lindenauer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatable Traits: a new paradigm for 21st century management of chronic airway diseases

(2019) Vanessa M. McDonald et al.   EUROPEAN RESPIRATORY JOURNAL

Treatable traits and their application in high-, middle- and low-income countries

(2019) Vanessa M. McDonald et al.   RESPIROLOGY

Targeting treatable traits in severe asthma: a randomised controlled trial

(2019) Vanessa M. McDonald et al.   EUROPEAN RESPIRATORY JOURNAL

Treatable traits of chronic airways disease

(2018) James Fingleton et al.   CURRENT OPINION IN PULMONARY MEDICINE

Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD + ): a randomised controlled trial

(2018) Louise Rose et al.   EUROPEAN RESPIRATORY JOURNAL

Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma

(2018) Diana M. Sobieraj et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

After asthma: redefining airways diseases

(2018) Ian D Pavord et al.   LANCET

Independent determinants of disease-related quality of life in COPD – scope for nonpharmacologic interventions?

(2018) Sarah B Brien et al.   International Journal of Chronic Obstructive Pulmonary Disease

Physiotherapy breathing retraining for asthma: a randomised controlled trial

(2018) Anne Bruton et al.   Lancet Respiratory Medicine

Inhaled corticosteroids in COPD: Friend or foe?

(2018) Alvar Agusti et al.   EUROPEAN RESPIRATORY JOURNAL

Treatable traits can be identified in a severe asthma registry and predict future exacerbations

(2018) Vanessa M. McDonald et al.   RESPIROLOGY

Triaging treatable traits in asthma

(2018) Christina Baggott et al.   RESPIROLOGY

Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD

(2018) Janwillem W. H. Kocks et al.   npj Primary Care Respiratory Medicine

Precision medicine in airway diseases: moving to clinical practice

(2017) Alvar Agustí et al.   EUROPEAN RESPIRATORY JOURNAL

Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993–2012)

(2017) Stefan Ebmeier et al.   LANCET

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

(2017) Ian D. Pavord et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sing Your Lungs Out—a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study

(2017) Amanda McNaughton et al.   BMJ Open

Eosinophils in COPD: just another biomarker?

(2017) Mona Bafadhel et al.   Lancet Respiratory Medicine

Device errors in asthma and COPD: systematic literature review and meta-analysis

(2017) Henry Chrystyn et al.   npj Primary Care Respiratory Medicine

A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use

(2016) Akke-Nynke van der Meer et al.   EUROPEAN RESPIRATORY JOURNAL

Treatable traits: toward precision medicine of chronic airway diseases

(2016) Alvar Agusti et al.   EUROPEAN RESPIRATORY JOURNAL

Validated questionnaires heighten detection of difficult asthma comorbidities

(2016) Naghmeh Radhakrishna et al.   JOURNAL OF ASTHMA

Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial

(2016) Fanny W S Ko et al.   THORAX

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices

(2016) Job van der Palen et al.   npj Primary Care Respiratory Medicine

Diagnosis and investigation in the severe asthma clinic

(2016) Peter A. B. Wark et al.   Expert Review of Respiratory Medicine

A summary of the new GINA strategy: a roadmap to asthma control

(2015) Helen K. Reddel et al.   EUROPEAN RESPIRATORY JOURNAL

Symptom- and fraction of exhaled nitric oxide–driven strategies for asthma control: A cluster-randomized trial in primary care

(2015) Persijn J. Honkoop et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

COPD and its comorbidities: Impact, measurement and mechanisms

(2015) Netsanet A. Negewo et al.   RESPIROLOGY

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

(2015) Steven Pascoe et al.   Lancet Respiratory Medicine

Why aren’t we doing better in asthma: time for personalised medicine?

(2015) Mike Thomas   npj Primary Care Respiratory Medicine

Digital Asthma Self-Management Interventions: A Systematic Review

(2014) Deborah Morrison et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?

(2013) Vanessa M McDonald et al.   THORAX

Efficacy and safety of maintenance and reliever combination budesonide–formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

(2013) Mitesh Patel et al.   Lancet Respiratory Medicine

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

(2012) Jørgen Vestbo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

(2012) Ian D Pavord et al.   LANCET

Pragmatic Trials — Guides to Better Patient Care?

(2011) James H. Ware et al.   NEW ENGLAND JOURNAL OF MEDICINE

A study of a multi-level intervention to improve non-adherence in difficult to control asthma

(2011) Jacqueline Gamble et al.   RESPIRATORY MEDICINE

How to set up a severe asthma service

(2011) VANESSA M. MCDONALD et al.   RESPIROLOGY

Lessons learned from variation in response to therapy in clinical trials

(2010) Stanley J. Szefler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

(2010) John R. Hurst et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of mortality in COPD

(2010) Bartolome R. Celli   RESPIRATORY MEDICINE

Influence of anxiety on health outcomes in COPD

(2010) M. D Eisner et al.   THORAX

Shared Treatment Decision Making Improves Adherence and Outcomes in Poorly Controlled Asthma

(2009) Sandra R. Wilson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cluster Analysis and Clinical Asthma Phenotypes

(2008) Pranab Haldar et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Brussels Declaration: the need for change in asthma management

(2008) S. Holgate et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of comorbidities on asthma

(2008) Mike Thomas et al.   Expert Review of Clinical Immunology

Breathing exercises for asthma: a randomised controlled trial

(2008) M Thomas et al.   THORAX

Importance of inhaler devices in the management of airway disease

(2007) J.C. Virchow et al.   RESPIRATORY MEDICINE